Literature DB >> 22290319

[Ectopic hormone secretion by neuroendocrine tumors].

C Hubold1, G Brabant.   

Abstract

Ectopic hormone production is a rare complication in neuroendocrine tumors. Tumors producing corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) are most commonly observed, leading to the classical symptoms of Cushing’s syndrome. Additionally, a very low percentage of neuroendocrine tumors can produce growth hormone-releasing hormone (GHRH) leading to classical features of acromegaly. Moreover, ectopic antidiuretic hormone (ADH) secretion has been described in neuroendocrine tumors presenting as hyponatremia due to the syndrome of inappropriate ADH secretion. Other ectopic hormone secretions, such as paraneoplastic gonadotropin release are rarely observed. Ectopic hormone secretion is not usually associated with a detectable pituitary mass and diagnosis is based on the measurement of circulating peptides. This is frequently assisted by imaging techniques, such as somatostatin receptor scintigraphy. Therapeutically a curative approach is the primary goal but in advanced tumors palliative treatment aims to control symptoms with the help of specific antihormonal compounds, such as somatostatin analogues.

Entities:  

Mesh:

Year:  2012        PMID: 22290319     DOI: 10.1007/s00108-011-2920-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

Review 1.  The diagnosis and differential diagnosis of Cushing's syndrome.

Authors:  P J Trainer; A Grossman
Journal:  Clin Endocrinol (Oxf)       Date:  1991-04       Impact factor: 3.478

2.  Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy.

Authors:  Peter W Butler; Craig S Cochran; Maria J Merino; Dao M Nguyen; David S Schrump; Phillip Gorden
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 3.  Long-term management with octreotide or cabergoline in ectopic corticotropin hypersecretion: case report and literature review.

Authors:  Oscar D Bruno; Karina Danilowicz; Marcos Manavela; Daniela Mana; Maria A Rossi
Journal:  Endocr Pract       Date:  2010 Sep-Oct       Impact factor: 3.443

4.  Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism.

Authors:  Yu-fang Bi; Rui-xin Liu; Lei Ye; Hai Fang; Xiao-ying Li; Wei-qing Wang; Ji Zhang; Kan-Kan Wang; Lei Jiang; Ting-wei Su; Zhong-yuan Chen; Guang Ning
Journal:  Endocr Relat Cancer       Date:  2009-07-22       Impact factor: 5.678

5.  The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.

Authors:  Saila Kauhanen; Marko Seppänen; Jari Ovaska; Heikki Minn; Jörgen Bergman; Pirkko Korsoff; Pasi Salmela; Juha Saltevo; Timo Sane; Matti Välimäki; Pirjo Nuutila
Journal:  Endocr Relat Cancer       Date:  2008-12-16       Impact factor: 5.678

6.  The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period.

Authors:  Olfred Hansen; Peter Sørensen; Karin Holmskov Hansen
Journal:  Lung Cancer       Date:  2009-06-16       Impact factor: 5.705

Review 7.  Imaging in covert ectopic ACTH secretion: a CT pictorial review.

Authors:  Paul A Sookur; Anju Sahdev; Andrea G Rockall; Andrea M Isidori; John P Monson; Ashley B Grossman; Rodney H Reznek
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

8.  Diagnostic accuracy of chromogranin A and calcitonin precursors measurements for the discrimination of ectopic ACTH secretion from Cushing's disease.

Authors:  Marina S Zemskova; Eric S Nylen; Nicholas J Patronas; Edward H Oldfield; Kenneth L Becker; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

9.  Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.

Authors:  M van Hoek; L J Hofland; Y B de Rijke; F H van Nederveen; R R de Krijger; P M van Koetsveld; S W J Lamberts; A J van der Lely; W W de Herder; R A Feelders
Journal:  J Clin Endocrinol Metab       Date:  2008-11-18       Impact factor: 5.958

Review 10.  Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results.

Authors:  Klaas P Koopmans; Oliver N Neels; Ido P Kema; Philip H Elsinga; Thera P Links; Elisabeth G E de Vries; Pieter L Jager
Journal:  Crit Rev Oncol Hematol       Date:  2009-04-09       Impact factor: 6.312

View more
  1 in total

1.  Molecular challenges of neuroendocrine tumors.

Authors:  Parthik Patel; Karina Galoian
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.